Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$574M |
| 2 |
TotalEnergies
TTE
|
+$573M |
| 3 |
MDLN
Medline Inc
MDLN
|
+$446M |
| 4 |
Micron Technology
MU
|
+$389M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$387M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.11B |
| 3 |
Mastercard
MA
|
+$557M |
| 4 |
Autodesk
ADSK
|
+$554M |
| 5 |
RNAM
Avidity Biosciences
RNAM
|
+$490M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 9.89% |
| 4 | Financials | 9.74% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Protagonist Therapeutics
PTGX
$8.72B
| $231M | 0.1% |
2,649,981
+1,549,160
| +141% | +$127M |
|
177
Credo Technology Group
CRDO
$38.8B
| $229M | 0.1% |
1,591,348
+1,422,391
| +842% | +$219M |
|
178
T-Mobile US
TMUS
$190B
| $229M | 0.1% |
1,126,529
-744,887
| -40% | -$158M |
|
179
Gilead Sciences
GILD
$162B
| $229M | 0.1% |
1,862,114
+203,652
| +12% | +$24.7M |
|
180
Vertiv
VRT
$110B
| $223M | 0.1% |
1,378,890
+45,666
| +3% | +$7.93M |
|
181
Marvell Technology
MRVL
$170B
| $221M | 0.1% |
2,606,464
+480,052
| +23% | +$42M |
|
182
Pfizer
PFE
$141B
| $219M | 0.1% |
8,786,084
+7,489,189
| +577% | +$189M |
|
183
Lennar Class A
LEN
$20.5B
| $219M | 0.1% |
2,127,225
+228,247
| +12% | +$27.6M |
|
184
Descartes Systems
DSGX
$6.09B
| $217M | 0.1% |
2,473,531
+203,614
| +9% | +$18.2M |
|
185
CRH
CRH
$68.7B
| $213M | 0.1% |
1,709,299
+156,151
| +10% | +$18.6M |
|
186
Applied Materials
AMAT
$410B
| $213M | 0.1% |
830,219
+724,759
| +687% | +$174M |
|
187
FirstService
FSV
$6.45B
| $213M | 0.1% |
1,367,564
+579,615
| +74% | +$94.3M |
|
188
Dynatrace
DT
$12.7B
| $213M | 0.1% |
4,907,027
-1,116,280
| -19% | -$52M |
|
189
Surgery Partners
SGRY
$1.98B
| $209M | 0.09% |
13,537,984
+501,401
| +4% | +$9.22M |
|
190
Crinetics Pharmaceuticals
CRNX
$8.87B
| $207M | 0.09% |
4,440,691
+581,900
| +15% | +$25.9M |
|
191
Veralto
VLTO
$23.2B
| $202M | 0.09% |
2,025,815
-361,848
| -15% | -$36.6M |
|
192
O'Reilly Automotive
ORLY
$75.1B
| $202M | 0.09% |
2,211,790
-183,493
| -8% | -$17.9M |
|
193
Coca-Cola
KO
$362B
| $200M | 0.09% |
2,865,027
+1,537,993
| +116% | +$107M |
|
194
Vanguard Total International Stock ETF
VXUS
$153B
| $200M | 0.09% |
2,648,030
+303,871
| +13% | +$22.7M |
|
195
Dollar Tree
DLTR
$24.1B
| $199M | 0.09% |
1,614,040
-380,014
| -19% | -$40.7M |
|
196
Merck
MRK
$323B
| $198M | 0.09% |
1,885,140
-230,401
| -11% | -$21.6M |
|
197
Sensient Technologies
SXT
$5.32B
| $196M | 0.09% |
2,084,311
-201,837
| -9% | -$19M |
|
198
AST SpaceMobile
ASTS
$17.4B
| $194M | 0.09% |
2,670,067
-132,247
| -5% | -$9.44M |
|
199
OSI Systems
OSIS
$3.58B
| $192M | 0.09% |
752,567
-247,724
| -25% | -$64.7M |
|
|
LGN
200
Legence Corp
LGN
$5.2B
| $189M | 0.08% |
4,401,402
+2,474,220
| +128% | +$97.8M |
|
Similar funds
Janus Henderson Group's Q4 2025 Portfolio in Review
As of Q4 2025, Janus Henderson Group held 2,496 positions worth $223B, up 1.9% from $219B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Janus Henderson Group's Q4 2025 filing shows 100 new, 812 increased, 609 reduced and 90 closed positions. Its largest new stake was TotalEnergies: 9,061,622 shares worth $591M. The largest sale was Meta Platforms (Facebook), an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2025 buy was TotalEnergies: 9,061,622 shares worth $591M.
- Janus Henderson Group added most to Workday in Q4 2025, an estimated $574M increase.
- Janus Henderson Group's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $1.19B.
- Janus Henderson Group fully exited Akero Therapeutics in Q4 2025, selling an estimated $298M.
- Janus Henderson Group's ten largest holdings make up 33% of its $223B portfolio in Q4 2025.
- Janus Henderson Group opened 100 new positions and closed 90 in Q4 2025.
- Janus Henderson Group's portfolio value rose 1.9% quarter-over-quarter to $223B.
Based on Janus Henderson Group's 13F filing for Q4 2025, filed 17 Feb 2026.